Herbal medicinal product: Ribis nigri folium, Ribes nigrum L., P: Draft published
Submitted by Anonymous (not verified) on 16 February 2026 - 7:53
Herbal medicinal product: Ribis nigri folium, Ribes nigrum L., P: Draft published
Draft European Union herbal monograph on Ribes nigrum L., folium - Revision 2
Submitted by Anonymous (not verified) on 16 February 2026 - 7:53
Draft European Union herbal monograph on Ribes nigrum L., folium - Revision 2
Veterinary medicines European public assessment report (EPAR): Emepax, maropitant, Status: Opinion
Submitted by Anonymous (not verified) on 13 February 2026 - 15:00
Veterinary medicines European public assessment report (EPAR): Emepax, maropitant, Status: Opinion
Summary of opinion: Suvaxyn PRRS MLV, 12/02/2026 Positive
Submitted by Anonymous (not verified) on 13 February 2026 - 15:00
Summary of opinion: Suvaxyn PRRS MLV, 12/02/2026 Positive
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 10-12 February 2026
Submitted by Anonymous (not verified) on 13 February 2026 - 15:00
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 10-12 February 2026
Summary of opinion: Bluevac BTV (previously Bluevac BTV8), 12/02/2026 Positive
Submitted by Anonymous (not verified) on 13 February 2026 - 15:00
Summary of opinion: Bluevac BTV (previously Bluevac BTV8), 12/02/2026 Positive
Concept paper for the revision of the guideline on veterinary good pharmacovigilance practices (VGVP) Module: Signal Management (EMA/522332/2021)
Submitted by Anonymous (not verified) on 13 February 2026 - 14:57
Concept paper for the revision of the guideline on veterinary good pharmacovigilance practices (VGVP) Module: Signal Management (EMA/522332/2021)
Highlights - 6th EMA-AESGP bilateral meeting
Submitted by Anonymous (not verified) on 13 February 2026 - 14:25
Highlights - 6th EMA-AESGP bilateral meeting
Medicinal products for human use: monthly figures - January 2026
Submitted by Anonymous (not verified) on 13 February 2026 - 14:21
Medicinal products for human use: monthly figures - January 2026
Human medicines European public assessment report (EPAR): Emtricitabine / Rilpivirine / Tenofovir Alafenamide Viatris, emtricitabine,rilpivirine,tenofovir alafenamide, Date of authorisation: 19/08/2025, Status: Authorised
Submitted by Anonymous (not verified) on 13 February 2026 - 14:20
Human medicines European public assessment report (EPAR): Emtricitabine / Rilpivirine / Tenofovir Alafenamide Viatris, emtricitabine,rilpivirine,tenofovir alafenamide, Date of authorisation: 19/08/2025, Status: Authorised